The company posted a total revenue from operations of Rs 9,154.4 crore
in FY20, up 0.5 per cent year-on-year, with international revenue of
Rs 7,124 crore contributing 78 per cent to the total revenue, its
annual report for fiscal year 2019-20 said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/focused-on-sustaining-operational-financial-performance-in-near-term-jubilant-life-sciences/articleshow/77701751.cms
No comments:
Post a Comment